![Bill Slattery](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Bill Slattery
Investor Relations Contact bij
OCULAR THERAPEUTIX, INC.
Profiel
Bill Slattery is Vice President-Investor Relations at Ocular Therapeutix, Inc. since 2024.
Mr. Slattery is an Account Manager at Burns McClellan, Inc. Mr. Slattery was VP-Investor Relations & Corporate Communications at ChemoCentryx, Inc.
Actieve functies van Bill Slattery
| Bedrijven | Functie | Begin |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Investor Relations Contact | 01-04-2024 |
Burns McClellan, Inc.
 Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public and investor relations services | Corporate Officer/Principal | - |
Eerdere bekende functies van Bill Slattery
| Bedrijven | Functie | Einde |
|---|---|---|
| CHEMOCENTRYX, INC. | Investor Relations Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
33
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
ChemoCentryx, Inc.
 ChemoCentryx, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes small molecule therapeutics for inflammatory, autoimmune diseases and cancer | Health Technology |
Ocular Therapeutix, Inc.
 Ocular Therapeutix, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and commercializes therapies for retinal diseases & conditions of the eye | Health Technology |
Burns McClellan, Inc.
Burns McClellan, Inc. Miscellaneous Commercial ServicesCommercial Services Provides public and investor relations services | Commercial Services |
